Press release
Filgrastim Market : Year 2022-2031 and its detail analysis by Focusing on Top Key Players like Amgen , Apotex , Kirin Holding, Novartis, Pfizer, Toksรถz Group
Filgrastim Market Size, share
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐จ๐ ๐ ๐ข๐ฅ๐ ๐ซ๐๐ฌ๐ญ๐ข๐ฆ ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐ - ๐๐๐๐๐-19 ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐ ๐๐ฅ๐จ๐๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/3643
Filgrastim is a recombinant form of natural G-CSF that stimulates the production of neutrophils. It was licensed for the treatment of low blood neutrophils in the United States in 1991. The World Health Organization (WHO) has declared filgrastim in the list of essential drugs as safe and effective drugs. Filgrastim was first developed by Amgen, Inc. and sold under the brand name Neupogen. A large number of biosimilar companies are involved in the manufacturing and marketing of Filgrastim across the world. Filgrastim costs about $200 in the US, around โฌ50 in the UK, and $100 in developing countries.
Factors such as increase in various diseases and increasing geriatric population are driving the growth of filgrastim market. In addition, the increasing pressure to reduce healthcare expenditure and increasing availability of filgrastim, due to its cost, is expected to boost the growth of this market. In addition, the increased demand for biosimilars in the treatment of neutropenia further erodes the market. However, the most common side effects of filgrastim include joint pain, chest pain, hair loss and nausea which hinders the growth of the market. On the other hand, increased investment in R&D programs for the development of effective and innovative biosimilars will provide more market opportunities.
๐๐ฉ๐๐๐ค ๐ญ๐จ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐ฑ๐ฉ๐๐ซ๐ญ -https://www.alliedmarketresearch.com/connect-to-analyst/3643
Moreover, this medication is used to treat neutropenia, a condition that occurs after bone marrow transplantation and chemotherapy. It's been used to treat a variety of malignancies as a supportive therapy. In the recent decade, there has been a major growth in cancer prevention in industrialized countries, as well as government-led campaigns to raise awareness of early treatment. These reasons are projected to propel the worldwide Filgrastim market forward. Approved biosimilars such as Grafeel, Colstim, Neukine, and Filcad, which are much cheaper and readily available in developing countries, are expected to fuel the growth of the global Filgrastim market.
๐๐๐๐๐ข๐ง๐ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐จ๐ ๐ ๐ข๐ฅ๐ ๐ซ๐๐ฌ๐ญ๐ข๐ฆ ๐๐๐ซ๐ค๐๐ญ
Abbott Laboratories
Amgen
Apotex
Cadila Pharmaceuticals
Dr. Reddy's Laboratories
Kirin Holding (Kyowa Kirin)
Novartis
Pfizer
Teva Pharmaceutical Industries Ltd.
Toksรถz Group
Key Market Segments
By Drug Type
Biologic
Biosimilar
By Distribution Channel
Hospital pharmacies
Retail pharmacies
Online pharmacies
By Indication
Chemotherapy induced Neutropenia
Chronic Neutropenia
Others
By Region
๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐?
Q1. What is the total market value of Filgrastim market report ?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Filgrastim market in 2021?
Q4. Which is base year calculated in the Filgrastim market report?
Q5. Which are the top companies hold the market share in Filgrastim market?
Q6. Which is the most influencing segment growing in the filgrastim report?
Q7. What are the key trends in the Filgrastim market report?
Q8. What are the market values / growth % of emerging countries?
๐๐ง๐ช๐ฎ๐ข๐ซ๐ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ :https://www.alliedmarketresearch.com/purchase-enquiry/3643
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ :
๐๐๐ก๐ข๐ณ๐จ๐ฉ๐ก๐ซ๐๐ง๐ข๐ ๐๐ซ๐ฎ๐ ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก, 2031 https://www.alliedmarketresearch.com/schizophrenia-drugs-market-A17082
๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ก๐ข๐ฌ๐ญ๐จ๐๐ก๐๐ฆ๐ข๐ฌ๐ญ๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก - 2031 https://www.alliedmarketresearch.com/immunohistochemistry-market-A11199
๐๐๐ซ๐๐ข๐๐ ๐ซ๐๐ก๐๐๐ข๐ฅ๐ข๐ญ๐๐ญ๐ข๐จ๐ง ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก - 2031 https://www.alliedmarketresearch.com/cardiac-rehabilitation-market-A11270
๐๐จ๐ฌ๐ฉ๐ข๐ญ๐๐ฅ ๐๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก - 2031 https://www.alliedmarketresearch.com/hospital-beds-market-A15374
๐๐ซ๐ญ๐ก๐จ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค - 2025 https://www.alliedmarketresearch.com/orthobiologics-market
๐๐๐ง๐๐จ๐ง ๐๐๐ฉ๐๐ข๐ซ ๐๐๐ซ๐ค๐๐ญ - 2031 - https://www.alliedmarketresearch.com/tendon-repair-market-A17088
Contact:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of ""Market Research Reports"" and ""Business Intelligence Solutions."" AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Filgrastim Market : Year 2022-2031 and its detail analysis by Focusing on Top Key Players like Amgen , Apotex , Kirin Holding, Novartis, Pfizer, Toksรถz Group here
News-ID: 2787115 • Views: โฆ
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collectโฆ
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growthโฆ
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil โฆ
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strictโฆ
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of โฆ
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise inโฆ
More Releases for Filgrastim
Filgrastim Injection Market Is Booming So Rapidly with Amgen, Sandoz, Teva Pharm โฆ
HTF Market Insights just released the Global Filgrastim Injection Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies Filgrastim Injection Market are:
Amgen, Sandoz, Teva Pharmaceutical,โฆ
2024 Filgrastim Biosimilars Market: Size, Growth, Share, Trends, Forecast To 203 โฆ
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Filgrastim Biosimilars Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.66 billion In 2028 Atโฆ
Filgrastim Biosimilars Global Market Analysis, Trends, Growth, Research And Fore โฆ
The filgrastim biosimilars market size has grown strongly in recent years. It will grow from $1.02 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to emerging markets growth, increase in patent expiration, government initiatives, increased healthcare expenditure, low cost of biosimilars, strong pipeline of drugs and increase in biopharmaceutical r&dโฆ
Filgrastim Biosimilars Market Size, Share And Trends Analysis Report 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company presents an extensive market research report on the Filgrastim Biosimilars Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,โฆ
Filgrastim Market Is Likely to Experience a Tremendous Growth by 2029
Filgrastim Market was valued at USD 992.8 million in 2022 and is expected to grow at a CAGR of 8% between 2023 and 2029. Filgrastim Market research involves carrying out thorough research on market to help newly emerging players in making calculated decision regarding which business ideas to follow. It is carried out to assess the viability of novel product or service. There are a few important goals can beโฆ
Filgrastim Market Report, History and Forecast 2023-2031
The report extensively examines the global Filgrastim market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Filgrastim. For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market for Filgrastim. Weโฆ
